Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol.
Clinical Strategies for Integrating Medication Interventions Into Behavioral Treatment for Adolescent ADHD: The Medication Integration Protocol.
复制标题
DOI：
10.1080/07317107.2014.967631
复制
发表时间：
2014-10-01
影响因子：
0.5
通讯作者：
Levin FR
中科院分区：
文献类型：
--
作者：
Hogue A;Bobek M;Tau GZ;Levin FR
注意力缺陷/多动障碍（ADHD）在参加行为健康服务的青少年中非常普遍，但在这个年龄组中仍然治疗不足。此外，青少年多动症的一线治疗，兴奋剂药物，在常规实践中未得到充分利用。本文简要介绍了三种行为干预措施，旨在促进更强的整合药物干预到青少年ADHD的治疗计划：家庭ADHD心理教育，以家庭为基础的药物决策，行为治疗师领导协调药物整合。然后介绍了药物整合方案（MIP），该方案将所有三种干预措施纳入五项任务方案：ADHD评估和药物咨询; ADHD心理教育和客户接受; ADHD症状和家庭关系; ADHD药物和家庭决策;药物管理和整合规划。文章最后强调了行为治疗师应该了解的关于不同环境和人群中药物整合的最佳实践：将药物干预纳入初级保健，管理药物优先事项和多药问题，为青少年提供ADHD药物治疗，以及MIP干预策略与日常实践条件的兼容性。
Attention-Deficit/Hyperactivity Disorder (ADHD) is highly prevalent among adolescents enrolled in behavioral health services but remains undertreated in this age group. Also the first-line treatment for adolescent ADHD, stimulant medication, is underutilized in routine practice. This article briefly describes three behavioral interventions designed to promote stronger integration of medication interventions into treatment planning for adolescent ADHD: family ADHD psychoeducation, family-based medication decision-making, and behavior therapist leadership in coordinating medication integration. It then introduces the Medication Integration Protocol (MIP), which incorporates all three interventions into a five-task protocol: ADHD Assessment and Medication Consult; ADHD Psychoeducation and Client Acceptance; ADHD Symptoms and Family Relations; ADHD Medication and Family Decision-Making; and Medication Management and Integration Planning. The article concludes by highlighting what behavior therapists should know about best practices for medication integration across diverse settings and populations: integrating medication interventions into primary care, managing medication priorities and polypharmacy issues for adolescents with multiple diagnoses, providing ADHD medications to adolescent substance users, and the compatibility of MIP intervention strategies with everyday practice conditions.
登录
查看更多内容
影响因子：
10.6
作者：
Biederman, J;Wilens, TE;Spencer, T
通讯作者：
Spencer, T
影响因子：
2.2
作者：
Henggeler, Scott W.;Sheidow, Ashli J.
通讯作者：
Sheidow, Ashli J.
影响因子：
6.4
作者：
Faraone, Stephen V.;Buitelaar, Jan
通讯作者：
Buitelaar, Jan
影响因子：
3.9
作者：
Chan, Ya-Fen;Dennis, Michael L.;Funk, Rodney R.
通讯作者：
Funk, Rodney R.
DOI：
10.15288/jsas.2005.s15.34
发表时间：
2005-07-01
期刊：
JOURNAL OF STUDIES ON ALCOHOL
影响因子：
--
作者：
Hosking, JD;Cisler, RA;Anton, RF
通讯作者：
Anton, RF